These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 8048799)
1. Aerobic training and diabetic nephropathy in the obese Zucker rat. Ward KM; Mahan JD; Sherman WM Ann Clin Lab Sci; 1994; 24(3):266-77. PubMed ID: 8048799 [TBL] [Abstract][Full Text] [Related]
2. Effect of aerobic training on diabetic nephropathy in a rat model of type 2 diabetes mellitus. Chiasera JM; Ward-Cook KM; McCune SA; Wardlaw GM Ann Clin Lab Sci; 2000 Oct; 30(4):346-53. PubMed ID: 11045758 [TBL] [Abstract][Full Text] [Related]
3. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats. Boor P; Celec P; Behuliak M; Grancic P; Kebis A; Kukan M; Pronayová N; Liptaj T; Ostendorf T; Sebeková K Metabolism; 2009 Nov; 58(11):1669-77. PubMed ID: 19608208 [TBL] [Abstract][Full Text] [Related]
4. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198 [TBL] [Abstract][Full Text] [Related]
5. Diabetic nephropathy in an aerobically trained rat model of diabetes. Albright AL; Mahan JD; Ward KM; Sherman WM; Roehrig KL; Kirby TE Med Sci Sports Exerc; 1995 Sep; 27(9):1270-7. PubMed ID: 8531625 [TBL] [Abstract][Full Text] [Related]
6. Effects of genetic obesity on renal structure and function in the Zucker rat. Kasiske BL; Cleary MP; O'Donnell MP; Keane WF J Lab Clin Med; 1985 Nov; 106(5):598-604. PubMed ID: 4056570 [TBL] [Abstract][Full Text] [Related]
7. Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat. Bach LA; Cooper ME; Vranes D; Allen TJ; Rumble J; Jerums G Diabetes Res; 1994; 27(1):27-38. PubMed ID: 7648794 [TBL] [Abstract][Full Text] [Related]
8. Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies. O'Donnell MP; Kasiske BL; Cleary MP; Keane WF J Lab Clin Med; 1985 Nov; 106(5):605-10. PubMed ID: 4056571 [TBL] [Abstract][Full Text] [Related]
9. Merit of physical exercise to reverse the higher gene expression of hepatic phosphoenolpyruvate carboxykinase in obese Zucker rats. Chang SP; Chen YH; Chang WC; Liu IM; Cheng JT Life Sci; 2006 Jun; 79(3):240-6. PubMed ID: 16458327 [TBL] [Abstract][Full Text] [Related]
10. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension. Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368 [TBL] [Abstract][Full Text] [Related]
11. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction. Nakano R; Kurosaki E; Shimaya A; Kajikawa S; Shibasaki M Eur J Pharmacol; 2006 Nov; 549(1-3):185-91. PubMed ID: 16989806 [TBL] [Abstract][Full Text] [Related]
12. Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. Chavers BM; Bilous RW; Ellis EN; Steffes MW; Mauer SM N Engl J Med; 1989 Apr; 320(15):966-70. PubMed ID: 2784542 [TBL] [Abstract][Full Text] [Related]
13. Anionic charge sites in the kidney: comparison of two diabetic rat models. Ward-Cook KM; Mahan JD; Frenchko CE; Albright A; Chiasera JM; McAllister C Ann Clin Lab Sci; 1999; 29(4):286-98. PubMed ID: 10528828 [TBL] [Abstract][Full Text] [Related]
14. Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin-dependent diabetes mellitus. Phillips AO; Baboolal K; Riley S; Gröne H; Janssen U; Steadman R; Williams J; Floege J Am J Kidney Dis; 2001 Feb; 37(2):400-10. PubMed ID: 11157383 [TBL] [Abstract][Full Text] [Related]
15. Structural involvement in type 1 and type 2 diabetic nephropathy. Dalla Vestra M; Saller A; Bortoloso E; Mauer M; Fioretto P Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968 [TBL] [Abstract][Full Text] [Related]
16. Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes. Schrijvers BF; De Vriese AS; Van de Voorde J; Rasch R; Lameire NH; Flyvbjerg A Nephrol Dial Transplant; 2004 May; 19(5):1092-7. PubMed ID: 14993490 [TBL] [Abstract][Full Text] [Related]
17. Mediation of beta-endorphin in exercise-induced improvement in insulin resistance in obese Zucker rats. Su CF; Chang YY; Pai HH; Liu IM; Lo CY; Cheng JT Diabetes Metab Res Rev; 2005; 21(2):175-82. PubMed ID: 15386812 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity. Baylis C; Atzpodien EA; Freshour G; Engels K J Pharmacol Exp Ther; 2003 Dec; 307(3):854-60. PubMed ID: 14560039 [TBL] [Abstract][Full Text] [Related]
19. Hyperphagia as a mediator of renal disease initiation in obese Zucker rats. Stevenson FT; Wheeldon CM; Gades MD; van Goor H; Stern JS Obes Res; 2001 Aug; 9(8):492-9. PubMed ID: 11500530 [TBL] [Abstract][Full Text] [Related]
20. Glycemia and exercise training alter glucose transport and GLUT4 in the Zucker rat. Sherman WM; Friedman JE; Gao JP; Reed MJ; Elton CW; Dohm GL Med Sci Sports Exerc; 1993 Mar; 25(3):341-8. PubMed ID: 8455449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]